Skip to content

YOKRIPHAR: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

YOKRIPHAR

BE 0450.379.413
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€147,949
2024 · €212,304-€64,355
Equity
€299,718
2024 · €701,769-€402,051
Cash
€118,464
2024 · €511,400-€392,935
Balance sheet total
€919,785
2024 · €757,293+€162,492

Largest movements

2024 to 2025
Assets
  • Current investments +€550,000

    new in 2025: €550,000

  • Cash -€392,935

    down €392,935 (-76.8%), from €511,400 to €118,464

    mainly Current investments (-€550,000) and Contributions, distributions and other (-€550,000)

  • Receivables within one year +€92,522

    up €92,522 (+1,253%), from €7,385 to €99,907

    of which Trade receivables: +€97,042

  • Deferred charges and accrued income -€78,216

    down €78,216 (-95.2%), from €82,123 to €3,907

Equity and liabilities
  • Other debts +€547,713

    new in 2025: €547,713

  • Profit (loss) carried forward -€360,923

    down €360,923 (-81.2%), from €444,492 to €83,569

  • Reserves -€41,129

    down €41,129 (-21.1%), from €195,277 to €154,149

    of which Distributable reserves: -€41,129

Income statement
  • Financial income -€36,140

    down €36,140 (-74.7%), from €48,413 to €12,272

    of which Non-recurring financial income: -€31,625

  • Gross operating margin -€15,374

    down €15,374 (-5.0%), from €307,685 to €292,311

  • Staff costs +€13,848

    up €13,848 (+21.8%), from €63,602 to €77,450

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €212,304
Gross operating margin -€15,374
Staff costs -€13,848
Depreciation +€140
Other operating charges -€45
Financial income -€36,140
Financial charges +€391
Taxes +€522
Result 2025 €147,949
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€707,065
Investment -€550,000
Financing -€550,000
Cash 2024 €511,400
Net result for the year +€147,949
Depreciation +€7,956
Stocks and contracts +€924
Receivables within one year -€92,522
Deferred charges and accrued income +€78,216
Trade debts +€8,566
Tax, wage and social debts +€8,264
Other debts +€547,713
Current investments -€550,000
Contributions, distributions and other -€550,000
Cash 2025 €118,464
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €757,293 €919,785 +€162,492 +21.5%
Fixed assets 21/28 €26,801 €18,846 -€7,956 -29.7%
Tangible fixed assets 22/27 €26,801 €18,846 -€7,956 -29.7%
Plant, machinery and equipment 23 €26,801 €18,846 -€7,956 -29.7%
Current assets 29/58 €730,492 €900,940 +€170,447 +23.3%
Stocks and contracts in progress 3 €129,585 €128,661 -€924 -0.7%
Stocks 30/36 €129,585 €128,661 -€924 -0.7%
Amounts receivable within one year 40/41 €7,385 €99,907 +€92,522 +1,253%
Trade receivables 40 €2,865 €99,907 +€97,042 +3,387%
Other amounts receivable 41 €4,520 - -€4,520
Current investments 50/53 - €550,000 +€550,000
Cash at bank and in hand 54/58 €511,400 €118,464 -€392,935 -76.8%
Deferred charges and accrued income 490/1 €82,123 €3,907 -€78,216 -95.2%
Total equity and liabilities 10/49 €757,293 €919,785 +€162,492 +21.5%
Equity 10/15 €701,769 €299,718 -€402,051 -57.3%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €195,277 €154,149 -€41,129 -21.1%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €189,077 €147,949 -€41,129 -21.8%
Profit (loss) carried forward 14 €444,492 €83,569 -€360,923 -81.2%
Amounts payable 17/49 €55,524 €620,067 +€564,543 +1,017%
Amounts payable within one year 42/48 €55,524 €620,067 +€564,543 +1,017%
Trade debts 44 €37,293 €45,859 +€8,566 +23.0%
Suppliers 440/4 €37,293 €45,859 +€8,566 +23.0%
Taxes, remuneration and social security 45 €18,231 €26,495 +€8,264 +45.3%
Taxes 450/3 €18,231 €17,163 -€1,068 -5.9%
Remuneration and social security 454/9 - €9,332 +€9,332
Other amounts payable 47/48 - €547,713 +€547,713
Remuneration, social security and pensions 62 €63,602 €77,450 +€13,848 +21.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €8,095 €7,956 -€140 -1.7%
Other operating charges 640/8 €1,351 €1,396 +€45 +3.4%
Gross operating margin 9900 €307,685 €292,311 -€15,374 -5.0%
Operating profit (loss) 9901 €234,637 €205,510 -€29,128 -12.4%
Financial income 75/76B €48,413 €12,272 -€36,140 -74.7%
Recurring financial income 75 €16,788 €12,272 -€4,515 -26.9%
Non-recurring financial income 76B €31,625 - -€31,625
Financial charges 65/66B €2,410 €2,019 -€391 -16.2%
Recurring financial charges 65 €2,410 €2,019 -€391 -16.2%
Profit (loss) for the period before taxes 9903 €280,640 €215,763 -€64,877 -23.1%
Income taxes 67/77 €68,336 €67,814 -€522 -0.8%
Profit (loss) for the period 9904 €212,304 €147,949 -€64,355 -30.3%
Profit (loss) for the period to be appropriated 9905 €212,304 €147,949 -€64,355 -30.3%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.